BIO-key International
BKYI
10 hedge funds and large institutions have $142K invested in BIO-key International in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% more ownership
Funds ownership: 0.01% → 0.02% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
24% less capital invested
Capital invested by funds: $186K → $142K (-$44.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$7.38K |
| 2 |
Renaissance Technologies
New York
|
+$6.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IPW
Impact Partnership Wealth
Marietta,
Georgia
|
-$544 |
| 2 |
JP Morgan Chase
New York
|
-$114 |
BKYI Hedge Fund Activity: Q3 2023 in Review
10 of the 6,308 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q3 2023, worth a combined $142K — down 24% from $186K a quarter earlier.
Fund positioning in BKYI was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $7.38K. The largest seller was Impact Partnership Wealth, exiting entirely with an estimated $544 sold.
- 10 institutional investors held BIO-key International (BKYI) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $142K of BIO-key International stock for Q3 2023, down 24% quarter-over-quarter.
- 1 fund opened new BIO-key International positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest BIO-key International buyer in Q3 2023 was Citadel Advisors, an estimated $7.38K added.
- The largest BIO-key International seller in Q3 2023 was Impact Partnership Wealth, an estimated $544 sold.
Based on aggregated 13F filings for Q3 2023.